CRNX (CRNX) Insider Trading

Track insider stock purchases and sales by company executives and directors.

Recent Insider Activity

Based on the last 100 transactions from Apr 17, 2024 - Apr 04, 2025

Filings
50
Purchases
0
Sales
29
Awards
13
Gifts
0
Exercise
0
Transaction Types Distribution

Based on 100 transactions from Apr 17, 2024 - Apr 04, 2025

Exercise/Conversion
Sale
Stock Award
Total Value$83.37M
Top Insider Selling by Transaction Value

Based on 100 transactions from 2024-04-17 - 2025-04-04

$6.48M$5.08M$2.93M$1.80M$1.42M$1.33MRichard StruthersRichard StruthersMarc WilsonMarc WilsonDana PizzutiDana PizzutiJeff KnightJeff KnightStephen BetzStephen BetzJames HassardJames Hassard$8.00M$8.00M$6.00M$6.00M$4.00M$4.00M$2.00M$2.00M$0.00$0.00
Recent Insider Transactions
Filing Date Insider Name Title Transaction Shares Value Shares Owned Details
April 4th, 2025 Richard Struthers Director, Officer: President & CEO Exercise 162.54K $310.45K 410.42K Form 4
Security Transaction Shares Price Value
Common Stock Exercise/Conversion 81270 $1.91 $155.23K
Stock Option (Right to Buy) Exercise/Conversion 81270 $1.91 $155.23K
March 21st, 2025 Dana Pizzuti Chief Med And Dev Officer Sale 2.52K $86.02K 72.36K Form 4
Security Transaction Shares Price Value
Common Stock Sale 2388 $34.17 $81.60K
Common Stock Sale 127 $34.83 $4.42K
March 21st, 2025 Jeff Knight Chief Operating Officer Sale 7.16K $244.96K 87.85K Form 4
Security Transaction Shares Price Value
Common Stock Sale 6801 $34.17 $232.39K
Common Stock Sale 361 $34.83 $12.57K
March 21st, 2025 Stephen Betz Chief Scientific Officer Sale 5.77K $197.35K 108.88K Form 4
Security Transaction Shares Price Value
Common Stock Sale 5479 $34.17 $187.22K
Common Stock Sale 291 $34.83 $10.14K
March 21st, 2025 Richard Struthers Director, Officer: President & CEO Sale 17.34K $593.02K 330.02K Form 4
Security Transaction Shares Price Value
Common Stock Sale 16463 $34.17 $562.54K
Common Stock Sale 875 $34.83 $30.48K
March 11th, 2025 Tobin Schilke Chief Financial Officer Stock Award 132.00K $2.70M 80.00K Form 4
Security Transaction Shares Price Value
Stock Option (Right to Buy) Stock Award 80000 $33.75 $2.70M
Common Stock Stock Award 52000 $0.00 $-
March 5th, 2025 Tobin Schilke - $- - Form 3
Security Transaction Shares Price Value
0 $0.00 $-
February 24th, 2025 Richard Struthers Director, Officer: President & CEO Stock Award 402.00K $11.54M 346.49K Form 4
Security Transaction Shares Price Value
Common Stock Stock Award 89000 $0.00 $-
Stock Option (Right to Buy) Stock Award 313000 $36.86 $11.54M
February 24th, 2025 Jeff Knight Chief Operating Officer Stock Award 108.00K $2.40M 94.65K Form 4
Security Transaction Shares Price Value
Common Stock Stock Award 43000 $0.00 $-
Stock Option (Right to Buy) Stock Award 65000 $36.86 $2.40M
February 24th, 2025 Dana Pizzuti Chief Med And Dev Officer Stock Award 108.00K $2.40M 74.75K Form 4
Security Transaction Shares Price Value
Common Stock Stock Award 43000 $0.00 $-
Stock Option (Right to Buy) Stock Award 65000 $36.86 $2.40M
February 24th, 2025 Stephen Betz Chief Scientific Officer Stock Award 108.00K $2.40M 114.36K Form 4
Security Transaction Shares Price Value
Common Stock Stock Award 43000 $0.00 $-
Stock Option (Right to Buy) Stock Award 65000 $36.86 $2.40M
February 5th, 2025 Dana Pizzuti Chief Med And Dev Officer Exercise Sale 15.00K $364.25K 119.04K Form 4
Security Transaction Shares Price Value
Stock option (Right to Buy) Exercise/Conversion 5000 $16.89 $84.45K
Common Stock Exercise/Conversion 5000 $16.89 $84.45K
Common Stock Sale 5000 $39.07 $195.35K
January 29th, 2025 Stephen Betz - $- - Form 5
Security Transaction Shares Price Value
0 $0.00 $-
January 29th, 2025 Marc Wilson - $- - Form 5
Security Transaction Shares Price Value
0 $0.00 $-
January 13th, 2025 Isabel Kalofonos Chief Commercial Officer Stock Award 100.00K $4.06M 100.00K Form 4
Security Transaction Shares Price Value
Stock Option (Right to Buy) Stock Award 100000 $40.59 $4.06M
January 7th, 2025 Dana Pizzuti Chief Med And Dev Officer Exercise Sale 50.00K $1.39M 124.04K Form 4
Security Transaction Shares Price Value
Stock option (Right to Buy) Exercise/Conversion 15000 $16.89 $253.35K
Common Stock Exercise/Conversion 15000 $16.89 $253.35K
Common Stock Exercise/Conversion 2500 $19.64 $49.10K
Common Stock Sale 15000 $52.09 $781.35K
Stock Option (Right to Buy) Exercise/Conversion 2500 $19.64 $49.10K
December 30th, 2024 Isabel Kalofonos - $- - Form 3
Security Transaction Shares Price Value
0 $0.00 $-
December 18th, 2024 Stephen Betz Chief Scientific Officer Exercise 4.66K $8.90K 180.04K Form 4
Security Transaction Shares Price Value
Stock Option (Right to Buy) Exercise/Conversion 2331 $1.91 $4.45K
Common Stock Exercise/Conversion 2331 $1.91 $4.45K
December 4th, 2024 Richard Struthers Director, Officer: President & CEO Sale 10.00K $575.70K 100.00K Form 4
Security Transaction Shares Price Value
Common Stock Sale 10000 $57.57 $575.70K
November 26th, 2024 Jeff Knight Chief Operating Officer Sale 501 $28.32K 51.65K Form 4
Security Transaction Shares Price Value
Common Stock Sale 501 $56.52 $28.32K
October 7th, 2024 Dana Pizzuti Chief Med And Dev Officer Exercise Sale 43.12K $1.27M 139.04K Form 4
Security Transaction Shares Price Value
Stock option (Right to Buy) Exercise/Conversion 14375 $16.89 $242.79K
Common Stock Exercise/Conversion 14375 $16.89 $242.79K
Common Stock Sale 14375 $54.63 $785.31K
September 30th, 2024 Marc Wilson CFO Exercise Sale 75.00K $2.04M 136.09K Form 4
Security Transaction Shares Price Value
Common Stock Exercise/Conversion 25000 $15.29 $382.25K
Common Stock Sale 25000 $51.11 $1.28M
Stock option (Right to Buy) Exercise/Conversion 25000 $15.29 $382.25K
September 12th, 2024 Stephen Betz Chief Scientific Officer Sale 1.03K $53.30K 68.58K Form 4
Security Transaction Shares Price Value
Common Stock Sale 1035 $51.50 $53.30K
August 28th, 2024 Stephen Betz Chief Scientific Officer Sale 3.00K $159.57K 69.61K Form 4
Security Transaction Shares Price Value
Common Stock Sale 3000 $53.19 $159.57K
August 14th, 2024 Stephen Betz Chief Scientific Officer Sale 3.00K $143.04K 72.61K Form 4
Security Transaction Shares Price Value
Common Stock Sale 3000 $47.68 $143.04K
July 26th, 2024 Stephen Betz Chief Scientific Officer Sale 3.00K $160.29K 75.61K Form 4
Security Transaction Shares Price Value
Common Stock Sale 3000 $53.43 $160.29K
July 26th, 2024 Marc Wilson CFO Exercise Sale 57.17K $1.38M 130.15K Form 4
Security Transaction Shares Price Value
Common Stock Exercise/Conversion 19056 $9.28 $176.84K
Common Stock Sale 19056 $53.88 $1.03M
Stock option (Right to Buy) Exercise/Conversion 19056 $9.28 $176.84K
July 17th, 2024 Jeff Knight Chief Operating Officer Exercise Sale 79.15K $2.66M 112.50K Form 4
Security Transaction Shares Price Value
Stock option (Right to Buy) Exercise/Conversion 17499 $23.98 $419.63K
Stock option (Right to Buy) Exercise/Conversion 5687 $19.64 $111.69K
Common Stock Exercise/Conversion 5687 $19.64 $111.69K
Common Stock Exercise/Conversion 2887 $20.02 $57.80K
Common Stock Exercise/Conversion 17499 $23.98 $419.63K
Common Stock Sale 27000 $55.00 $1.49M
Stock option (Right to Buy) Exercise/Conversion 2887 $20.02 $57.80K
July 17th, 2024 Marc Wilson CFO Exercise Sale 75.00K $2.38M 136.09K Form 4
Security Transaction Shares Price Value
Common Stock Exercise/Conversion 25000 $20.02 $500.50K
Common Stock Sale 25000 $55.00 $1.38M
Stock option (Right to Buy) Exercise/Conversion 25000 $20.02 $500.50K
July 12th, 2024 Stephen Betz Chief Scientific Officer Sale 3.00K $145.65K 78.61K Form 4
Security Transaction Shares Price Value
Common Stock Sale 3000 $48.55 $145.65K
July 9th, 2024 James Hassard Chief Commercial Officer Exercise Sale 45.00K $1.25M 130.00K Form 4
Security Transaction Shares Price Value
Stock option (Right to Buy) Exercise/Conversion 15000 $19.73 $295.95K
Common Stock Exercise/Conversion 15000 $19.73 $295.95K
Common Stock Sale 15000 $44.08 $661.20K
July 5th, 2024 Dana Pizzuti Chief Med And Dev Officer Exercise Sale 43.12K $1.13M 153.42K Form 4
Security Transaction Shares Price Value
Stock option (Right to Buy) Exercise/Conversion 14375 $16.89 $242.79K
Common Stock Exercise/Conversion 14375 $16.89 $242.79K
Common Stock Sale 14375 $44.87 $645.01K
July 2nd, 2024 Marc Wilson CFO Exercise Sale 96.39K $2.00M 143.22K Form 4
Security Transaction Shares Price Value
Common Stock Exercise/Conversion 32129 $9.28 $298.16K
Common Stock Sale 32129 $43.61 $1.40M
Stock option (Right to Buy) Exercise/Conversion 32129 $9.28 $298.16K
June 28th, 2024 Jeff Knight Chief Operating Officer Sale 956 $42.43K 52.58K Form 4
Security Transaction Shares Price Value
Common Stock Sale 956 $44.38 $42.43K
June 26th, 2024 Stephen Betz Chief Scientific Officer Sale 3.00K $136.11K 80.64K Form 4
Security Transaction Shares Price Value
Common Stock Sale 3000 $45.37 $136.11K
June 25th, 2024 Dana Pizzuti Chief Med And Dev Officer Exercise Sale 28.50K $782.33K 167.79K Form 4
Security Transaction Shares Price Value
Stock option (Right to Buy) Exercise/Conversion 9500 $19.73 $187.44K
Common Stock Exercise/Conversion 9500 $16.89 $160.46K
Common Stock Sale 9500 $45.73 $434.43K
June 24th, 2024 James Hassard Chief Commercial Officer Exercise Sale 45.00K $1.26M 145.00K Form 4
Security Transaction Shares Price Value
Stock option (Right to Buy) Exercise/Conversion 15000 $19.73 $295.95K
Common Stock Exercise/Conversion 15000 $19.73 $295.95K
Common Stock Sale 15000 $44.66 $669.90K
June 11th, 2024 Stephen Betz Chief Scientific Officer Sale 3.00K $131.58K 83.64K Form 4
Security Transaction Shares Price Value
Common Stock Sale 3000 $43.86 $131.58K
June 11th, 2024 Caren Deardorf Director Stock Award 15.90K $558.88K 12.50K Form 4
Security Transaction Shares Price Value
Stock Option (right to buy) Stock Award 12500 $44.71 $558.88K
Common Stock Stock Award 3400 $0.00 $-
June 11th, 2024 Coelho Vivaldi Director Stock Award 15.90K $558.88K 14.40K Form 4
Security Transaction Shares Price Value
Common Stock Stock Award 3400 $0.00 $-
Stock Option (right to buy) Stock Award 12500 $44.71 $558.88K
June 11th, 2024 Stephanie Okey Director Stock Award 15.90K $558.88K 12.50K Form 4
Security Transaction Shares Price Value
Stock Option (right to buy) Stock Award 12500 $44.71 $558.88K
Common Stock Stock Award 3400 $0.00 $-
June 11th, 2024 Weston Nichols Director Stock Award 15.90K $558.88K 12.50K Form 4
Security Transaction Shares Price Value
Stock Option (right to buy) Stock Award 12500 $44.71 $558.88K
Common Stock Stock Award 3400 $0.00 $-
June 11th, 2024 Matthew Fust Director Stock Award 15.90K $558.88K 21.94K Form 4
Security Transaction Shares Price Value
Common Stock Stock Award 3400 $0.00 $-
Stock Option (right to buy) Stock Award 12500 $44.71 $558.88K
June 11th, 2024 Camille Bedrosian Director Stock Award 15.90K $558.88K 12.50K Form 4
Security Transaction Shares Price Value
Stock Option (right to buy) Stock Award 12500 $44.71 $558.88K
Common Stock Stock Award 3400 $0.00 $-
June 11th, 2024 Wendall Wierenga Director Stock Award 15.90K $558.88K 109.25K Form 4
Security Transaction Shares Price Value
Common Stock Stock Award 3400 $0.00 $-
Stock Option (right to buy) Stock Award 12500 $44.71 $558.88K
May 30th, 2024 Stephen Betz Chief Scientific Officer Sale 3.00K $142.47K 86.64K Form 4
Security Transaction Shares Price Value
Common Stock Sale 3000 $47.49 $142.47K
May 14th, 2024 Stephen Betz Chief Scientific Officer Sale 3.00K $148.29K 89.64K Form 4
Security Transaction Shares Price Value
Common Stock Sale 3000 $49.43 $148.29K
May 10th, 2024 Richard Struthers Director, Officer: President & CEO Exercise Sale 322.34K $7.30M 364.93K Form 4
Security Transaction Shares Price Value
Common Stock Exercise/Conversion 107448 $9.28 $997.12K
Common Stock Sale 107448 $49.40 $5.31M
Stock Option (Right to Buy) Exercise/Conversion 107448 $9.28 $997.12K
April 22nd, 2024 Richard Struthers Director, Officer: President & CEO Gift 350 $- 257.49K Form 4
Security Transaction Shares Price Value
Common Stock Gift 350 $0.00 $-
April 17th, 2024 Dana Pizzuti Chief Med And Dev Officer Exercise 14.38K $242.79K 177.29K Form 4
Security Transaction Shares Price Value
Stock option (Right to Buy) Exercise/Conversion 14375 $16.89 $242.79K

Related Metrics

Explore detailed financial metrics and analysis for CRNX.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio